Stephen E Alway Selected Research

Stephen E Alway Research Topics

Disease

9	Muscular Atrophy (Muscle Atrophy) 07/2020 - 08/2003
9	Hypertrophy 01/2012 - 01/2003
7	Atrophy 07/2020 - 04/2007
5	Sarcopenia 10/2014 - 07/2002
3	AIDS-Related Complex (ARC) 03/2009 - 07/2005
2	Inflammation (Inflammations) 01/2021 - 12/2012
2	Insulin Resistance 01/2021 - 12/2008
2	Ischemic Stroke 07/2020 - 01/2020
2	Stroke (Strokes) 07/2020 - 01/2020
2	Fatigue 01/2019 - 01/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 12/2015 - 12/2008
2	Obesity 12/2010 - 10/2008
2	Body Weight (Weight, Body) 12/2008 - 03/2006
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Muscular Dystrophies (Muscular Dystrophy) 11/2011
1	Starvation 11/2011
1	Cachexia 01/2011
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2008
1	Emphysema 07/2007
1	Myositis (Idiopathic Inflammatory Myopathies) 02/2007
1	Lacerations 02/2007
1	Fibrosis (Cirrhosis) 02/2007
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 11/2006
1	Neoplasms (Cancer) 11/2005
1	Hyperplasia 03/2004

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2002
3	Sirtuin 1IBA 01/2021 - 01/2019
3	ResveratrolIBA 01/2014 - 07/2011
3	SuspensionsIBA 09/2011 - 03/2006
3	Messenger RNA (mRNA)IBA 07/2007 - 01/2003
2	RNA (Ribonucleic Acid)IBA 01/2020 - 07/2005
2	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2018 - 11/2006
2	TeaIBA 02/2015 - 01/2014
2	Nonesterified Fatty Acids (NEFA)IBA 01/2012 - 12/2008
2	LipidsIBA 01/2012 - 10/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2003 - 01/2003
1	3,16-dihydroxyandrost-5-ene-17,19-dioneIBA 01/2021
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	CalciumIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Muscle Proteins (Muscle Protein)IBA 01/2020
1	Particulate MatterIBA 12/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2014
1	C-Reactive ProteinIBA 12/2012
1	AntioxidantsIBA 12/2012
1	PalmitatesIBA 01/2012
1	Docosahexaenoic AcidsIBA 01/2012
1	M-cadherinIBA 11/2011
1	Leucine (L-Leucine)FDA Link 09/2011
1	PolyphenolsIBA 07/2011
1	AICA ribonucleotide (ZMP)IBA 12/2010
1	Mechanistic Target of Rapamycin Complex 1IBA 12/2010
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2009
1	UbiquitinIBA 01/2009
1	Biomarkers (Surrogate Marker)IBA 10/2008
1	A-factor (Streptomyces)IBA 08/2008
1	Xylazine (Xylazin)IBA 07/2007
1	Pancreatic Elastase (Elastase)IBA 07/2007
1	Ketamine FDA LinkGeneric 07/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2007
1	Interleukin-15 (Interleukin 15)IBA 04/2007
1	CardiotoxinsIBA 02/2007
1	CytokinesIBA 02/2007
1	Transforming Growth Factor beta (TGF-beta)IBA 02/2007
1	Protein Isoforms (Isoforms)IBA 11/2006
1	CreatineIBA 11/2006
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2006
1	DNA (Deoxyribonucleic Acid)IBA 11/2005
1	X-Linked Inhibitor of Apoptosis ProteinIBA 08/2005
1	Inhibitor of Apoptosis ProteinsIBA 07/2005
1	CaspasesIBA 07/2005
1	Caspase 3 (Caspase-3)IBA 07/2005
1	CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA 07/2005
1	CollagenIBA 03/2004
1	Green Fluorescent ProteinsIBA 03/2004
1	Myogenic Regulatory FactorsIBA 08/2003
1	Isoflurane FDA LinkGeneric 06/2003

Therapy/Procedure

5	Denervation 01/2009 - 03/2003
2	Resistance Training 01/2011 - 10/2005
2	Anesthesia 07/2007 - 06/2003
1	Therapeutics 11/2011
1	Endurance Training 07/2005